Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Cancer|December 19, 2018
A phase 2 trial of regorafenib as a single agent in patients with chemotherapy-refractory, advanced, and metastatic biliary tract adenocarcinomaWeijing Sun, Anuj Patel, Daniel Normolle, et al.
Plos Pathogens|August 13, 2013
Blocking TLR7- and TLR9-mediated IFN-α production by plasmacytoid dendritic cells does not diminish immune activation in early SIV infectionMuhamuda Kader, Amanda P Smith, Cristiana Guiducci, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2012
Dosimetric analysis of radiation-induced gastric bleedingMary Feng, Daniel Normolle, Charlie C Pan, et al.
Cancer|April 10, 2004
Dysplasia in Barrett esophagusChristopher D Lao, Melanie Simmons, Sapna Syngal, et al.
Translational Oncology|August 31, 2014
Phase I trial of radiotherapy concurrent with twice-weekly gemcitabine for head and neck cancer: translation from preclinical investigations aiming to improve the therapeutic ratioAron Popovtzer, Daniel Normolle, Francis P Worden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
Gene amplification in esophageal adenocarcinomas and Barrett's with high-grade dysplasiaCharles T Miller, Justin R Moy, Lin Lin, et al.
Anticancer Research|July 11, 2006
Tetrathiomolybdate blocks bFGF- but not VEGF-induced incipient angiogenesis in vitroFatema Mamou, Kerstin S May, Matthew J Schipper, et al.
Medical Physics|March 29, 2007
The prediction of radiation-induced liver dysfunction using a local dose and regional venous perfusion modelYue Cao, Joel F Platt, Isaac R Francis, et al.
International Journal of Radiation Oncology, Biology, Physics|July 28, 2004
Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabineAaron M Allen, Mark M Zalupski, John M Robertson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignanciesEdgar Ben-Josef, Daniel Normolle, William D Ensminger, et al.
Pageof 6